Rickinson AB - Search Results

1

Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, Rickinson AB, Moss PA. Khan N, et al. Among authors: rickinson ab. J Immunol. 2004 Dec 15;173(12):7481-9. doi: 10.4049/jimmunol.173.12.7481. J Immunol. 2004. PMID: 15585874

2

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Murray RJ, et al. Among authors: rickinson ab. J Exp Med. 1992 Jul 1;176(1):157-68. doi: 10.1084/jem.176.1.157. J Exp Med. 1992. PMID: 1319456 Free PMC article.

3

Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.

Murray RJ, Brooks JM, Rickinson AB, Rowe M. Murray RJ, et al. Among authors: rickinson ab. Eur J Immunol. 1990 Mar;20(3):659-64. doi: 10.1002/eji.1830200329. Eur J Immunol. 1990. PMID: 1690661

4

In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.

Strang G, Rickinson AB. Strang G, et al. Among authors: rickinson ab. Immunology. 1987 Dec;62(4):647-54. Immunology. 1987. PMID: 2828228 Free PMC article.

5

In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.

Ulaeto D, Wallace L, Morgan A, Morein B, Rickinson AB. Ulaeto D, et al. Among authors: rickinson ab. Eur J Immunol. 1988 Nov;18(11):1689-97. doi: 10.1002/eji.1830181106. Eur J Immunol. 1988. PMID: 2904885

6

Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.

Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB. Lee SP, et al. Among authors: rickinson ab. Eur J Immunol. 1995 Jan;25(1):102-10. doi: 10.1002/eji.1830250119. Eur J Immunol. 1995. PMID: 7531142

7

EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.

Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ. Khanna R, et al. Among authors: rickinson ab. J Immunol. 1993 Jun 1;150(11):5154-62. J Immunol. 1993. PMID: 7684421

8

MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.

Lee SP, Wallace LE, Mackett M, Arrand JR, Searle PF, Rowe M, Rickinson AB. Lee SP, et al. Among authors: rickinson ab. Int Immunol. 1993 May;5(5):451-60. doi: 10.1093/intimm/5.5.451. Int Immunol. 1993. PMID: 8391306

9

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.

Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ. Callan MF, et al. Among authors: rickinson ab. Nat Med. 1996 Aug;2(8):906-11. doi: 10.1038/nm0896-906. Nat Med. 1996. PMID: 8705861

10

Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.

Lee SP, Thomas WA, Blake NW, Rickinson AB. Lee SP, et al. Among authors: rickinson ab. Eur J Immunol. 1996 Aug;26(8):1875-83. doi: 10.1002/eji.1830260831. Eur J Immunol. 1996. PMID: 8765034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters